| [1] | 徐利君, 徐仙娥, 林利芬. 镇静催眠药物的研究进展[J]. 海峡药学, 2014, 26(11):17-21. |
| [2] | 李洪涛, 吴秀云, 赵芹,等. 氟马西尼对丙泊酚复合舒芬太尼全麻患者血浆中食欲素A的影响[J]. 中国临床研究, 2017, 30(5):592-595. |
| [3] | Trotti LM, Saini P, Koola C, et al. Flumazenil for the treatment of refractory hypersomnolence:clinical experience with 153 patients[J]. J Clin Sleep Med, 2016, 12(10):1389-1394. |
| [4] | 王芝燕. 地西泮-布洛芬栓制备及质量标准研究[J]. 临床合理用药杂志, 2016, 9(35):89-90. |
| [5] | 叶晨静, 龚艳春. 失眠症的临床治疗及效果评定[J]. 中国实用医药, 2017, 12(6):124-125. |
| [6] | 刘正. 建立镇静催眠药临床前药效学评价方法和研究西红花有效成分的催眠作用及机制[D]. 上海:复旦大学, 2010. |
| [7] | 中华人民共和国卫生部. 新药(西药)临床前研究指导原则汇编[M]. 中华人民共和国卫生部药政局, 1993. |
| [8] | Forouzanfar F, Hosseini A, Amiri M S, et al. Potentiating effects of Perovskia abrotanoides Karel. on pentobarbital-induced sleep[J]. Avicenna J Phytomed, 2017, 7(3):214-222. |
| [9] | Koga N, Yamaguchi T, Lee KK, et al. Kososan,a standardized traditional Japanese herbal medicine, reverses sleep disturbance in socially isolated mice via GABAA-benzodiazepine receptor complex activation[J]. Phytomedicine, 2014, 21(5):697-703. |
| [10] | Roncari G, Ziegler WH, Guentert TW. Pharmacokinetics of the new benzodiazepine antagonist Ro 15-1788 in man following intravenous and oral administration[J]. Br J Clin Pharmacol, 1986, 22(4):421-428. |
| [11] | Klotz U, Kanto J. Pharmacokinetics and clinical use of flumazenil (Ro 15-1788)[J]. ClinPharmacokinet, 1988, 14(1):1-12. |
| [12] | Kasteleijn-Nolst Trenite DG, Groenwold RH, Schmidt B,et al. Single dose efficacy evaluation of two partial benzodiazepine receptor agonists in photosensitive epilepsy patients:A placebo-controlled pilot study[J]. Epilepsy Res, 2016, 122:30-36. |